SINOMAB BIO-中国抗体-B(03681.HK)完成根据一般授权发行2496.54万股认购股份

中国抗体-B(03681.HK)完成根据一般授权发行2496.54万股认购股份

SINOMAB BIO(HK:03681) Ge Long Hui·2025-08-29 11:11

Group 1 - The company China Antibody-B (03681.HK) announced the completion of the subscription of a total of 24,965,400 shares according to the terms and conditions of the relevant subscription agreements with subscribers H and O on August 29, 2025 [1]